Frustrated with Limited Results?
BPH medications like Flomax™ (tamsulosin), Proscar™ (finasteride), and Avodart™ (dutasteride) can help, but they might not be giving you the relief you need. Additionally, some of these medications have been linked to potential risks, including heart failure.1
of men surveyed aren’t satisfied with how well their BPH medication works.2
Stuck between BPH medications and surgery
We get it – having a procedure sounds painful and not worth the hassle. Enlarged prostates are just part of life...right? We're here to provide a different solution.
The UroLift™ System provides a proven treatment that can get men off BPH medications and avoid major surgery.6
The UroLift™ System: A Minimally Invasive BPH Solution That Fits Your Life
The UroLift™ System is a straightforward procedure that lifts and holds enlarged prostate tissue out of the way so it no longer blocks the urethra, providing lasting relief without medications or invasive surgery.6 It's the #1 chosen minimally invasive procedure in the U.S.3

Why Choose the UroLift™ System?
The UroLift™ System is the leading minimally invasive procedure designed to treat BPH symptoms without cutting, heating, or removing prostate tissue.4,7
Outpatient Procedure: Typically performed as a same-day procedure under local anesthesia5
Safe and Effective: Lower risk profile compared to surgical options like TURP4,6,8,9
Rapid Symptom Relief: Provides faster relief than medications4,10
Preserves Sexual Function: Shown not to cause new or lasting sexual dysfunction6*
Widely Covered: Accepted by Medicare and most insurance plans when medical criteria are met
Low Catheterization: Most patients do not need a catheter after treatment4,5


Get Free BPH Information
References
1. Lusty, J Urol 2021
2. Survey of US men aged 40+ who have been diagnosed with BPH (enlarged prostate) and are/have been treated with BPH medications, conducted by Teleflex in 2020. Data on file, n=96
3. U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018-21, as is and with no representations/warranties, including accuracy or completeness.
- 4. Roehrborn, J Urology 2013
5. Shore, Can J Urol 2014
6. Roehrborn, Can J Urol 2017
- 7. AUA Guidelines 2003, 2020
- 8. Sonksen, Eur Urol 2015
- 9. AUA BPH Guidelines 2003
10. Roehrborn, et al, AUA 2024. IMPACT Study: Preliminary RCT Analysis of Minimally Invasive Surgery vs. Medication in the Initial Treatment of BPH-Associated LUTS.
* No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study
† As with any medical procedure, individual results may vary. See patient safety for more information.
‡ UroLift™ System Patient Ambassadors share their personal experience – they do not provide medical advice. Individual results may vary.
MAC02982-02 Rev A